Industry & Policy News

[Nature News] The number of retractions issued for research articles in 2023 has passed 10,000 — smashing annual records — as publishers struggle to clean up a slew of sham papers and peer-review fraud.

[Rowan University] Dr. Sebastián Vega, an assistant professor of biomedical engineering at Rowan University, is investigating why stem cells lose their identity outside the body, as well as new ways to grow such cells in the lab.

[Weill Cornell Medicine] PICI announced it has added Weill Cornell Medicine to its network of preeminent academic and medical research institutions at the forefront of the fight against cancer.

89bio, Inc. announced a successful end-of-phase II Meeting with the US FDA, supporting the advancement of pegozafermin into Phase III in NASH. The program will include two Phase 3 trials evaluating...

[The University of Toronto] The University of Toronto’s Medicine by Design initiative and CCRM, a non-profit that supports the development and commercialization of regenerative medicines, are launching a new strategic alliance that aims to unlock Toronto’s potential as a world-leading ecosystem for regenerative medicine.

[Icosavax, Inc.] Icosavax, Inc. announced positive topline interim results from its Phase II clinical trial of IVX-A12 against respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) in older adults.